Elisabetta Mereu
Home
Posts
Projects
Publications
Contact
Navarro A
Latest
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC).
Cite
×